30,954 Shares in Danaher Corporation $DHR Purchased by Daiichi Life Insurance Co. Ltd.

Daiichi Life Insurance Co. Ltd. acquired a new position in Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 30,954 shares of the conglomerate’s stock, valued at approximately $5,896,000.

A number of other institutional investors have also recently bought and sold shares of DHR. Main Street Group LTD bought a new position in shares of Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher during the fourth quarter worth approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $219.42 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a 50 day simple moving average of $195.80 and a 200 day simple moving average of $192.61.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 EPS. Research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analysts Set New Price Targets

DHR has been the topic of a number of recent research reports. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Wells Fargo & Company decreased their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. DZ Bank initiated coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Finally, Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Check Out Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.